Barclays lowered the firm’s price target on Ryan Specialty (RYAN) to $41 from $45 and keeps an Overweight rating on the shares. The firm adjusted targets in the insurance group as part of a Q1 preview. Premium growth and broker organic growth “are likely to remain sluggish,” the analyst tells investors in a research note. However, Barclays sees solid margins and strong capital deployment still contributing to reported book value growth in Q1.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty price target lowered to $49 from $55 at Keefe Bruyette
- Ryan Specialty price target lowered to $50 from $55 at Morgan Stanley
- Ryan Specialty price target lowered to $55 from $60 at Citi
- Ryan Specialty price target lowered to $45 from $52 at Barclays
- Ryan Specialty price target lowered to $44 from $53 at Mizuho